Concepts (65)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tomography, X-Ray Computed | 6 | 2013 | 871 | 0.740 |
Why?
|
| Maxillary Sinus | 1 | 2011 | 6 | 0.400 |
Why?
|
| Facial Bones | 1 | 2011 | 10 | 0.400 |
Why?
|
| Facial Injuries | 1 | 2011 | 13 | 0.400 |
Why?
|
| Skull Fractures | 1 | 2011 | 17 | 0.390 |
Why?
|
| Skull | 1 | 2006 | 45 | 0.280 |
Why?
|
| Brain Mapping | 1 | 2006 | 182 | 0.270 |
Why?
|
| Bone Density | 1 | 2006 | 182 | 0.260 |
Why?
|
| Brain Edema | 1 | 2003 | 16 | 0.230 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2003 | 24 | 0.220 |
Why?
|
| Brain | 1 | 2006 | 930 | 0.170 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2008 | 142 | 0.130 |
Why?
|
| Head and Neck Neoplasms | 2 | 2008 | 117 | 0.130 |
Why?
|
| Ear | 1 | 2013 | 18 | 0.120 |
Why?
|
| Temporal Bone | 1 | 2013 | 17 | 0.120 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2013 | 20 | 0.120 |
Why?
|
| Adult | 5 | 2011 | 8426 | 0.110 |
Why?
|
| Sex Characteristics | 1 | 2013 | 167 | 0.110 |
Why?
|
| Male | 6 | 2013 | 17815 | 0.090 |
Why?
|
| Female | 6 | 2013 | 18173 | 0.090 |
Why?
|
| Oropharyngeal Neoplasms | 1 | 2008 | 13 | 0.080 |
Why?
|
| Middle Aged | 4 | 2011 | 10834 | 0.080 |
Why?
|
| Radiotherapy | 1 | 2008 | 74 | 0.080 |
Why?
|
| Deglutition Disorders | 1 | 2008 | 50 | 0.080 |
Why?
|
| Radiation Injuries | 1 | 2008 | 67 | 0.080 |
Why?
|
| Lymph Node Excision | 1 | 2008 | 89 | 0.080 |
Why?
|
| Phantoms, Imaging | 1 | 2006 | 56 | 0.070 |
Why?
|
| Reference Values | 1 | 2006 | 224 | 0.070 |
Why?
|
| Humans | 7 | 2013 | 29123 | 0.070 |
Why?
|
| Infant | 2 | 2013 | 969 | 0.070 |
Why?
|
| Child, Preschool | 2 | 2013 | 1167 | 0.060 |
Why?
|
| Aged, 80 and over | 3 | 2008 | 3719 | 0.060 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2008 | 401 | 0.060 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2006 | 242 | 0.060 |
Why?
|
| Neck Dissection | 1 | 2004 | 9 | 0.060 |
Why?
|
| Tomography, Emission-Computed | 1 | 2004 | 25 | 0.060 |
Why?
|
| Young Adult | 1 | 2011 | 2402 | 0.060 |
Why?
|
| Retrospective Studies | 3 | 2013 | 3112 | 0.060 |
Why?
|
| Cerebral Ventriculography | 1 | 2003 | 3 | 0.060 |
Why?
|
| Subarachnoid Space | 1 | 2003 | 5 | 0.060 |
Why?
|
| Intracranial Pressure | 1 | 2003 | 19 | 0.060 |
Why?
|
| Child | 2 | 2013 | 2219 | 0.050 |
Why?
|
| Lymphatic Metastasis | 3 | 2008 | 156 | 0.050 |
Why?
|
| Cerebral Cortex | 1 | 2003 | 141 | 0.050 |
Why?
|
| Diagnosis, Differential | 1 | 2003 | 493 | 0.050 |
Why?
|
| Aged | 3 | 2008 | 9492 | 0.050 |
Why?
|
| Radiotherapy Dosage | 2 | 2008 | 98 | 0.040 |
Why?
|
| Combined Modality Therapy | 2 | 2008 | 525 | 0.040 |
Why?
|
| Sex Factors | 1 | 2013 | 631 | 0.020 |
Why?
|
| Risk Factors | 2 | 2008 | 3537 | 0.020 |
Why?
|
| Carboplatin | 1 | 2008 | 40 | 0.020 |
Why?
|
| Paclitaxel | 1 | 2008 | 50 | 0.020 |
Why?
|
| Cisplatin | 1 | 2008 | 69 | 0.020 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2008 | 163 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2008 | 281 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2008 | 440 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2008 | 436 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2008 | 709 | 0.020 |
Why?
|
| Adolescent | 1 | 2013 | 3255 | 0.020 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2004 | 56 | 0.010 |
Why?
|
| Radiopharmaceuticals | 1 | 2004 | 88 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2008 | 546 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2004 | 532 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2004 | 2021 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2004 | 1219 | 0.010 |
Why?
|